PL337003A1 - Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs - Google Patents

Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs

Info

Publication number
PL337003A1
PL337003A1 PL98337003A PL33700398A PL337003A1 PL 337003 A1 PL337003 A1 PL 337003A1 PL 98337003 A PL98337003 A PL 98337003A PL 33700398 A PL33700398 A PL 33700398A PL 337003 A1 PL337003 A1 PL 337003A1
Authority
PL
Poland
Prior art keywords
caprophen
cox
dogs
selectively acting
inflammatory states
Prior art date
Application number
PL98337003A
Other languages
English (en)
Inventor
Krystin Marie Lundy
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL337003A1 publication Critical patent/PL337003A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
PL98337003A 1997-05-05 1998-05-01 Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs PL337003A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (fr) 1997-05-05 1998-05-01 Carprofene inhibant selectivement cox-2 et utilise dans le traitement de la douleur et des inflammations chez les chiens

Publications (1)

Publication Number Publication Date
PL337003A1 true PL337003A1 (en) 2000-07-31

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98337003A PL337003A1 (en) 1997-05-05 1998-05-01 Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs

Country Status (32)

Country Link
EP (1) EP0988034A1 (fr)
JP (1) JP2000513020A (fr)
KR (2) KR20040004406A (fr)
CN (1) CN1255059A (fr)
AP (1) AP9801234A0 (fr)
AR (2) AR011726A1 (fr)
AU (1) AU6932198A (fr)
BG (1) BG103852A (fr)
BR (1) BR9808720A (fr)
CA (1) CA2288759A1 (fr)
DZ (1) DZ2479A1 (fr)
EA (1) EA003696B1 (fr)
GT (1) GT199800063A (fr)
HR (1) HRP980244A2 (fr)
HU (1) HUP0001286A3 (fr)
ID (1) ID21311A (fr)
IL (1) IL132570A0 (fr)
IS (1) IS5220A (fr)
MA (1) MA26491A1 (fr)
NO (1) NO995389L (fr)
NZ (1) NZ500183A (fr)
OA (1) OA11213A (fr)
PA (1) PA8450601A1 (fr)
PE (1) PE72599A1 (fr)
PL (1) PL337003A1 (fr)
SK (1) SK148199A3 (fr)
TN (1) TNSN98059A1 (fr)
TW (1) TW590773B (fr)
UY (1) UY24989A1 (fr)
WO (1) WO1998050033A1 (fr)
YU (1) YU55899A (fr)
ZA (1) ZA983722B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
CA2347365A1 (fr) * 1998-10-23 2000-05-04 Merck Frosst Canada & Co. Produit de combinaison comprenant un ligand de prostaglandine de type e et un inhibiteur selectif de cox-2, et procedes d'utilisation dudit produit
NZ513965A (en) * 1999-03-10 2004-04-30 G Method and composition for administering a cyclooxygenase-2 inhibitor
AU1592901A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US20020016342A1 (en) * 2000-05-15 2002-02-07 Edward Scolnick Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor
EA011309B1 (ru) 2000-06-13 2009-02-27 Вайет Составы для ослабления боли, содержащие целекоксиб
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
AU8475301A (en) 2000-08-07 2002-02-18 Univ Vanderbilt Detection of cox-2 activity and anandamide metabolites
WO2003007875A2 (fr) * 2001-07-16 2003-01-30 Hoegestaett Edward Substances organoleptiques d'acetaminophene et composes associes utilises comme substrats pour conjugaison d'acides gras et utilisation de ces substances dans le traitement de la douleur, de la fievre et des inflammations
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
CA2533101A1 (fr) * 2003-07-31 2005-02-03 Pharmacia & Upjohn Company Llc Formulation dispersable d'un agent anti-inflammatoire
EP1940380A2 (fr) * 2005-05-20 2008-07-09 Pfizer Limited Combinaisons synergiques des medicaments anti-inflammatoires non steroidiens avec des ligands alpha-2 delta
EP2061440A2 (fr) * 2007-04-04 2009-05-27 Sigmoid Pharma Limited Composition pharmaceutique à base de tacrolimus
ES2963291T3 (es) 2007-04-26 2024-03-26 Sublimity Therapeutics Ltd Fabricación de múltiples minicápsulas
ES2530049T3 (es) 2009-05-18 2015-02-26 Sigmoid Pharma Limited Composición que comprende gotas de aceite
BR112012002963A2 (pt) 2009-08-12 2017-10-24 Sigmoid Pharma Ltd composições imunomoduladoras compreendendo uma matriz de polímero e uma fase oleosa
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
CN105939713A (zh) * 2014-03-06 2016-09-14 阿莱塔纳治疗学股份有限公司 格拉匹纶组合物及其使用方法
EA036036B1 (ru) 2014-11-07 2020-09-16 Сигмойд Фарма Лимитед Композиции, содержащие циклоспорин
WO2016112312A1 (fr) * 2015-01-09 2016-07-14 Jaguar Animal Health Méthodes de traitement de la diarrhée chez des animaux de compagnie
JP2023520367A (ja) * 2020-03-25 2023-05-17 エスアールアイ インターナショナル リポキシゲナーゼ阻害剤
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (fr) * 1987-02-03 1993-07-06 Alberto Ferro Solutions de micelles mixtes

Also Published As

Publication number Publication date
AU6932198A (en) 1998-11-27
IL132570A0 (en) 2001-03-19
PE72599A1 (es) 1999-08-12
HUP0001286A3 (en) 2000-12-28
BG103852A (en) 2000-06-30
HRP980244A2 (en) 1999-02-28
EA003696B1 (ru) 2003-08-28
WO1998050033A1 (fr) 1998-11-12
JP2000513020A (ja) 2000-10-03
DZ2479A1 (fr) 2003-02-01
GT199800063A (es) 1999-10-26
EP0988034A1 (fr) 2000-03-29
EA199900895A1 (ru) 2000-06-26
UY24989A1 (es) 2001-10-25
ID21311A (id) 1999-05-20
AR039628A2 (es) 2005-03-02
SK148199A3 (en) 2001-09-11
AR011726A1 (es) 2000-08-30
NZ500183A (en) 2002-04-26
TW590773B (en) 2004-06-11
MA26491A1 (fr) 2004-12-20
OA11213A (en) 2003-07-14
BR9808720A (pt) 2000-07-11
YU55899A (sh) 2003-08-29
NO995389D0 (no) 1999-11-04
AP9801234A0 (en) 1999-11-04
NO995389L (no) 2000-01-04
CA2288759A1 (fr) 1998-11-12
KR20010012300A (ko) 2001-02-15
TNSN98059A1 (fr) 2005-03-15
HUP0001286A2 (hu) 2000-11-28
CN1255059A (zh) 2000-05-31
IS5220A (is) 1999-10-19
PA8450601A1 (es) 2000-05-24
KR20040004406A (ko) 2004-01-13
ZA983722B (en) 1999-11-04

Similar Documents

Publication Publication Date Title
ZA983722B (en) Cox-2 selective carprofen for treating pain and inflammation in dogs.
PL336758A1 (en) Substituted imidazoles useful in treating inflammatory states
HUP0004484A3 (en) Desaturase genes and their use
ATE318746T1 (de) Lasttragende und steuerbare einheit
DE69738406D1 (de) Verbesserungen in oder an Kontrastmitteln
DE69817302D1 (de) Verbesserungen an/und im Zusammenhang mit Ventilen
DE69726118D1 (de) Energiesparender passtransistorlogikschaltkreis und volladdierer damit
DE69832027D1 (de) Integriertes kraft-und steuerungssystem
DE69836460D1 (de) Übertragungsgerät und Lastverteilungsübertragungsverfahren im Übertragungsgerät
GB9704162D0 (en) Assay methods and means
AU5871898A (en) Microparticles and their use in cancer treatment
AU7368198A (en) Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals
GB9814645D0 (en) Data-processing device and method
DE69628756D1 (de) Kombinierte longitudinale und transversale Spurnachführung
GB9624587D0 (en) Improvements in and relating magnetic bearings
PL339804A1 (en) Application of thiazolydine diones in treating hyperglycaemia
GB9625666D0 (en) Improvements in construction and control
ZA972543B (en) Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
GB9705561D0 (en) Localized object and domestic cat locateing device
AU7334398A (en) Transgenic animal with controllable hyperproliferation and inflammation phenotype in the skin
BR7601188U (pt) Disposiçao introduzida em carteira
PL339813A1 (en) Application of thiazolydine diones in treating hyperglycaemia
BR9705337A (pt) Aperfeiçoamento introduzidos em duchas chuveiros eletricos e outros
GB9726490D0 (en) Hydraulic power arrangement and method
GB9603168D0 (en) Microorganisms and their use in treating silage